P&R Strategy
CARVE™: Continued Access Reinforced by Value Evidence Global Pricing Strategy Development Reimbursement and Payer Pathway Mapping
CARVE™: Continued Access Reinforced by Value Evidence
Proprietary strategic platform developed to address the increasing Payer needs for evidence based access (such as pay for performance, outcomes based contracting), and provides contracting strategies to optimize or maintain access
- CARVE™ generates real world evidence to support product’s clinical and/or economic benefits to enhance value / support price
- A Platform which assesses existing Payer value drivers and needs, product(s) positioning, and evidence repository (product and competitors), to support existing contracting strategies
- Best ROI strategies to modify existing evidence generation strategies and/or contracting models
- Supports needs for alternative contracting models which align with Payer needs while supporting EvGen plans for execution & monitoring
How can CARVE™ help?
The CARVE™ tool helps a manufacturer manage alternative access contracts given market forces such as Payer evaluation of access renewal, competitive threats, generic/biosimilar availability, etc.
Global Pricing Strategy Development
MKTXS pricing services assist manufacturers in determining and optimizing their assets’ price using robust price elicitation techniques customized to the perceived assets’ value
- MKTXS has successfully advised manufacturers on strategies minimizing/limiting price erosion, such as indication launch sequencing, and tiered pricing in an increasingly complex and value-based pricing landscape
- Given recent trends, such as external price referencing, parallel trade, and increasing generic/biosimilar threats, MKTXS has provided price-optimizing roadmaps for use in the global marketplace
Our pricing expertise includes:
Price Waterfall
Indication-specific pricing
External / international reference pricing mitigation tactics
Innovative pricing/access strategies
Tiered pricing
Price segmentation strategies
Reimbursement and Payer Pathway Mapping
MKTXS can map reimbursement pathways to identify points of influence thus allowing for targeted approach to optimize price and access
Payer Pathway Mapping
MKTXS is proficient in mapping the payer and influencer pathway, especially for innovative therapies requiring new modes of administration
Services by Product Development Phase (non-exhaustive)
Opportunity Assessment
Early evidence generation & trial design
Value proposition to maximize access at optimal price
Shaping Payer perception and revenue optimization
Request a Call Back
Contact us to request a quote or to schedule a consultation with our team.
+1 908-864-4090